Skip to main content

No Time For Pfizer, Europe Heads Back

Europe’s problems are more immediate. Encouraging news about Pfizer’s vaccine won’t change the European circumstances in near enough time to avoid what’s more and more looking like a real possibility for a retrenchment.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.